Vaughn M Kailian
CIK 1180429 · President and CEO · last filed 2015-07-21
Vaughn M Kailian is a President and CEO who has filed 12 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CHMA, was dated Jul 21, 2015. Across all open-market trades the lifetime net is +$5.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $296.4M across reported positions. 35 SEC filings were submitted jointly with Ansbert Gadicke.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PCRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BODEGA, CA 94922
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHIASMA, INC (CHMA) Delisted | 10%+ Owner | 10,426 | $3.76 | $39.2K | $0 | 1 | 2015-07-21 |
| Histogen Inc. (CNAT) Delisted | 10%+ Owner | 102,682 | — | — | $1.82M | 1 | 2013-08-01 |
| CEPHALON INC (CEPH) Delisted | Director | — | — | — | $0 | 6 | 2011-10-17 |
| PCRX | 10%+ Owner | 2,828,941 | $36.48 | $103.20M | $3.75M | 1 | 2011-02-10 |
| MEMY | President and CEO | 14,228,773 | $13.58 | $193.22M | -$153.7K | 3 | 2008-02-12 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-21 | CHIASMA, INC (CHMA) Delisted | Conv (C) | +5,681,544 | $0 | EDGAR |
| 2013-08-01 | Histogen Inc. (CNAT) Delisted | Mixed | +1,192,080 | $2.00M | EDGAR |
| 2011-10-17 | CEPHALON INC (CEPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2011-05-12 | CEPHALON INC (CEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-10 | PCRX | Mixed | +2,735,961 | $3.75M | EDGAR |
| 2010-05-21 | CEPHALON INC (CEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-14 | CEPHALON INC (CEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-27 | CEPHALON INC (CEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-12 | MEMY | Grant (A) | — | $0 | EDGAR |
| 2007-09-14 | MEMY | Sell (S) | −72,180 | -$153.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.